Education
About Us
Working with TipRanks
Follow Us
COSMO Pharmaceuticals N.V. (CH:COPN)
:COPN
COPN Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF54.10 - CHF80.60
Previous CloseN/A
Volume25.75K
Average Volume (3M)N/A
Market Cap
CHF914.29M
Enterprise ValueN/A
Total Cash (Recent Filing)€110.39M
Total Debt (Recent Filing)€164.84M
Price to Earnings (P/E)7.0
Beta0.98
Next Earnings
Jul 23, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.57%
Share Statistics
EPS (TTM)7.77
Shares Outstanding17,543,522
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF108.50Price Target Upside76.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Bulls Say, Bears Say
Bulls Say
FDA ClearanceGI Genius poised for further advances with FDA clearance for latest-generation module 300 hardware.
Revenue GrowthPreliminary unaudited revenue demonstrates strength with a 186% year-over-year increase.
Bears Say
Regulatory ApprovalMultiple additional catalysts expected, including potential approval for Winlevi in Europe.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.34% Mutual Funds
― Other Institutional Investors
94.70% Public Companies and
Individual Investors
COPN FAQ
What was COSMO Pharmaceuticals N.V.’s price range in the past 12 months?
COSMO Pharmaceuticals N.V. lowest stock price was CHF54.10 and its highest was CHF80.60 in the past 12 months.
What is COSMO Pharmaceuticals N.V.’s market cap?
COSMO Pharmaceuticals N.V.’s market cap is CHF914.29M.
When is COSMO Pharmaceuticals N.V.’s upcoming earnings report date?
COSMO Pharmaceuticals N.V.’s upcoming earnings report date is Jul 23, 2025 which is in 135 days.
How were COSMO Pharmaceuticals N.V.’s earnings last quarter?
Currently, no data Available
Is COSMO Pharmaceuticals N.V. overvalued?
According to Wall Street analysts COSMO Pharmaceuticals N.V.’s price is currently Undervalued.
Does COSMO Pharmaceuticals N.V. pay dividends?
COSMO Pharmaceuticals N.V. pays a N/A dividend of CHF1.912 which represents an annual dividend yield of 3.57%. See more information on COSMO Pharmaceuticals N.V. dividends here
What is COSMO Pharmaceuticals N.V.’s EPS estimate?
COSMO Pharmaceuticals N.V.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does COSMO Pharmaceuticals N.V. have?
COSMO Pharmaceuticals N.V. has 17,543,522 shares outstanding.
What happened to COSMO Pharmaceuticals N.V.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of COSMO Pharmaceuticals N.V.?
Currently, no hedge funds are holding shares in CH:COPN
---
Company Description
COSMO Pharmaceuticals N.V.
Cosmo Pharmaceuticals NV is a major drug manufacturing company with a focus on specialty pharmaceuticals. Its clinical development pipeline maintains a focus on treatments for inflammatory bowel disease, colorectal cancer diagnosis, and colonoscopy. The company's business model involves identifying market opportunities, creating a corresponding product, advancing through the clinical trials, and then partnering its product into a specialty pharma company with strong marketing and sales expertise by taking an equity stake in the partner. While the equity stake can later be divested, Cosmo retains exclusive manufacturing of all the products it develops.
---
COPN Stock 12 Month Forecast
Average Price Target
CHF108.50
▲(76.42% Upside)
Best Analysts Covering COPN
1 Year
1 Year Success Rate
4/11 ratings generated profit
1 Year Average Return
+13.70%
reiterated a buy rating 5 days ago
Copying Nicolas Pauillac's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of +13.70% per trade.
---